(Q45057353)

9 December 2017

title

Antihypertensive efficacy of candesartan-lisinopril in combination vs. up-titration of lisinopril: the AMAZE trials (English)

1 reference

9 December 2017

Joseph L Izzo

1

1 reference

9 December 2017

Marc S Weinberg

2

1 reference

9 December 2017

James W Hainer

3

1 reference

9 December 2017

Joseph Kerkering

4

1 reference

9 December 2017

Conrad K P Tou

5

1 reference

9 December 2017

AMAZE

6

1 reference

9 December 2017

publication date

1 September 2004

1 reference

Journal of Clinical Hypertension

9 December 2017

published in

1 reference

9 December 2017

volume

6

1 reference

9 December 2017

issue

9

1 reference

9 December 2017

page(s)

485-493

1 reference

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03511.X

Angiotensin II receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03511.X

Use of ramipril in preventing stroke: double blind randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03511.X

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03511.X

Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03511.X

Comparative safety and tolerability of angiotensin II receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03511.X

Efficacy of candesartan cilexetil as add-on therapy in hypertensive patients uncontrolled on background therapy: a clinical experience trial. ACTION Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03511.X

Reduction of proteinuria; combined effects of receptor blockade and low dose angiotensin-converting enzyme inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03511.X

Randomized controlled crossover study of the effect on proteinuria and blood pressure of adding an angiotensin II receptor antagonist to an angiotensin converting enzyme inhibitor in normotensive patients with chronic renal disease and proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03511.X

Dual blockade of the renin-angiotensin system in diabetic nephropathy: a randomized double-blind crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03511.X

The effect of high-dose angiotensin II receptor blockade beyond maximal recommended doses in reducing urinary protein excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03511.X

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03511.X

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03511.X

Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03511.X

Effects of dual blockade of the renin-angiotensin system in primary proteinuric nephropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03511.X

Angiotensin II antagonists for hypertension: are there differences in efficacy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03511.X

10.1111/J.1524-6175.2004.03511.X

21 January 2018

Identifiers

DOI

1 reference

9 December 2017

1 reference